Amgen, Inc. (AMGN)

pnshark (95.54) Submitted: 3/26/07 8:51 PM : Start Price: $57.18 AMGN Score: 22.25

at a 52 week low - may go lower, but can't resist picking up AMGN at these prices.

Report this Post Replies: 0 | Reply | Permalink

johnqueuepublic (< 20) Submitted: 3/15/07 12:51 PM : Start Price: $60.16 AMGN Score: 16.23

Aranesp issues not well understood by street. So far street is overreacting in a big way. Earnings will show the street is wrong and Amgen will come back into vogue. Off-label use of any drug is a crapshoot...on-label Aranesp is safe and makes up ...

Report this Post Replies: 0 | Reply | Permalink

ranshdow (98.67) Submitted: 8/16/07 1:46 PM : Start Price: $48.72 AMGN Score: 36.04

This small pharma company is excellently run. While I disagree with the decision to lay off 2600 employees (this is a killer for long-term health of the company), they know how to recruit, retain and managed the kinds of scientists that go on to make...

Report this Post Replies: 2 | Reply | Permalink

xmilkman207 (26.53) Submitted: 2/16/08 10:49 AM : Start Price: $47.17 AMGN Score: 38.03

this biotech is ready to get it together.

Report this Post Replies: 0 | Reply | Permalink

donflamenco (56.42) Submitted: 3/18/07 7:18 PM : Start Price: $59.75 AMGN Score: 16.56

Great valuation for the best biotech in the game. Tough to understand these bio's so I bet on the reputation and valuation.

Report this Post Replies: 0 | Reply | Permalink

nemaline (97.60) Submitted: 3/19/07 2:36 PM : Start Price: $59.23 AMGN Score: 17.64

AMGN is hitting 52-week lows along with a lot of panic selling re. its epo-like drugs and recent black box warnings. Sounds like a reason to jump in to me!

Report this Post Replies: 0 | Reply | Permalink

graffg (90.39) Submitted: 3/20/07 9:49 AM : Start Price: $59.21 AMGN Score: 17.84

Get it while its low, current FDA issues will improve and the drugs in question will keep being used. Pipeline looks promising.

Report this Post Replies: 0 | Reply | Permalink

dameanchen (62.75) Submitted: 9/08/07 8:20 AM : Start Price: $50.85 AMGN Score: 34.90

-How could Amgn, one of the most successful Biotech company in history, selling at a forward PE of 11. Even assuming an extreme worst case that BioGenerics start eating into share; the forward PE will only rise to 15. I am more than glad pay for tha...

Report this Post Replies: 0 | Reply | Permalink

volvo544 (43.58) Submitted: 3/21/07 6:23 PM : Start Price: $60.60 AMGN Score: 17.38

Great company.
Product line looks good.
Why stock price falling?
It'll be a winner shortly!

Report this Post Replies: 0 | Reply | Permalink

bangajanga (< 20) Submitted: 2/04/08 8:17 PM : Start Price: $46.43 AMGN Score: 39.36

Forward P/E of 12? Are you kidding me?

Report this Post Replies: 0 | Reply | Permalink